FDA Approval of New Medication for Atopic Dermatitis (RINVOQ)
adminmderm2022-02-08T22:59:38+00:00We wanted to take a moment to highlight information shared in one of our prior blog posts following the recent, January 14th, FDA approval [...]
National Psoriasis Action/Awareness Month 2021
adminmderm2021-07-29T16:29:42+00:00August marks the start of National Psoriasis Awareness Month, a time where we can shine a light on psoriasis, its symptoms, treatments and support those who experience any of its manifestations....
Congratulations Cristina!! (25-Year Work Anniversary)
adminmderm2021-06-22T21:49:46+00:00Cristina has been an integral part of TDA and MDRI for a combined quarter of a century!! This is a remarkable achievement! Thank you so much for all your efforts over the last 25-years (since 1996)...
Congratulations Catherine!! (20-Year Work Anniversary)
adminmderm2021-06-22T21:53:01+00:00Catherine has been at TDA and MDRI for a combined 20-years!! This is an amazing achievement and a testament to the lasting relationship between the team and the providers...
Welcome to the Newest Members of the MDRI Team – Krystal & Tiffany
adminmderm2021-06-22T21:56:50+00:00MDRI would like to warmly welcome the two newest members of the MDRI team!! Krystal started with us in December of 2020 as a Clinical Research Assistant, and Tiffany in January of 2021...
Upcoming Psoriasis “Walk for the Cure” Events
adminmderm2021-06-22T21:47:28+00:00The National Psoriasis Foundation has several fundraising and awareness spreading efforts throughout the year. A staple of these events...
Dr. Alan Menter Named to Dermatology Times 2020 Giants of Dermatology
adminmderm2021-07-29T20:15:14+00:00Dr. Menter has a long-held interest in psoriasis and psoriatic disease research that has spanned everything from ultraviolet phototherapy and new biologic therapy to the mapping of genetic patterns...
Happy Clinical Trials Day 2021
adminmderm2021-07-16T15:43:57+00:00Happy Clinical Trials Day!! The Menter Dermatology Research Institute would like to take this opportunity to thank all of our current and past trial participants...